Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent
1977-04-29
1978-10-03
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reduced antigenicity, reduced ability to bind complement, or...
2601125R, A61K 3700, C07C10352, C07G 700
Patent
active
041184815
ABSTRACT:
A demaino kallikrein-trypsin inhibitor obtained from cattle organs is characterized by (a) 0 to 3 lysine residues and/or 3 to 6 arginine residues and/or 1 to 4 tyrosine residues; (b) the 10- and/or 21-tyrosine residues being unsubstituted or substituted by at least one nitro, nitroso or amino in the ortho position relative to the phenolic hydroxy group; and (c) having protease inhibitory activity of BPTI and elastase inhibition activity.
REFERENCES:
anderer, F. A., et al., Ann. New York Acad. Sci. 146, 381 (1968).
Reinhardt Gerd
Schlumberger Horst Dieter
Schnabel Eugen
Truscheit Ernst
Tschesche Harald
Bayer Aktiengesellschaft
Hazel Blondel
Phillips Delbert R.
LandOfFree
Deamino derivatives of the kallikrein-trypsin inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Deamino derivatives of the kallikrein-trypsin inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Deamino derivatives of the kallikrein-trypsin inhibitor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1802010